Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The ongoing SARS-CoV2 outbreak has developed into a global pandemic. Despite previous outbreaks of SARS-CoV and the related MERS-CoV in recent years, neither a vaccine nor any other medication for an effective treatment are currently available. Endo-lysosomal two-pore cation channels have now emerged as potential novel targets for SARS-CoV treatment.

Original publication

DOI

10.1016/j.ceca.2020.102212

Type

Journal article

Journal

Cell Calcium

Publication Date

06/2020

Volume

88

Keywords

Covid-19, Lysosome, SARS-CoV2, TPC, TPC2, Two-pore channel, Animals, Betacoronavirus, COVID-19, Calcium Channel Blockers, Calcium Channels, Coronavirus Infections, Humans, Ion Channels, Lysosomes, Middle East Respiratory Syndrome Coronavirus, Pandemics, Pneumonia, Viral, Protein Transport, SARS-CoV-2, Severe Acute Respiratory Syndrome, Two-Pore Channels